NEUP

Neuphoria Therapeutics Inc. NASDAQ Listed Dec 16, 2021

Healthcare ·Medical - Pharmaceuticals ·US · neuphoriatx.com

$3.38

-4.79% vs $3.55

Mkt Cap $5.5M

52w Low $3.38 0.0% of range 52w High $20.00

50d MA $4.82 200d MA $5.71

P/E (TTM) -0.3x

EV/EBITDA —

P/B 0.2x

Debt/Equity 0.0x

ROE —

P/FCF 0.1x

RSI (14) 23.90

ATR (14) $0.34

Beta 0.48

50d MA $4.82

200d MA $5.71

Avg Volume 92.9K

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

CIK (SEC)

1191070

Phone

781-439-5551

100 Summit Dr · Burlington · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 17, 2026	AMC	-0.56	-0.77	-37.5%	4.06	+1.0%	+8.9%	-3.4%	+1.9%	-0.9%	+1.9%	—
Nov 14, 2025	AMC	-0.55	-4.41	-701.8%	4.79	-1.7%	-1.9%	+0.9%	-6.8%	-4.8%	+5.9%	—
Sep 29, 2025	AMC	-0.56	-5.79	-933.9%	11.86	-5.2%	-0.6%	+17.5%	+5.7%	+32.9%	+2.8%	—
May 20, 2025	AMC	-0.47	6.55	+1493.6%	5.40	+3.7%	+2.4%	+12.7%	+8.8%	-0.6%	-3.3%	—
Mar 17, 2025	AMC	-2.01	-0.01	+99.6%	5.00	+0.2%	-2.0%	+3.5%	+2.2%	+3.9%	+0.4%	—
Nov 15, 2024	AMC	—	-0.00	—	3.49	+1.4%	-0.9%	+3.2%	-5.0%	-1.8%	+6.0%	—
Sep 30, 2024	AMC	-11.38	-29.16	-156.2%	5.27	+7.0%	-11.2%	-16.5%	-14.6%	+2.7%	-4.4%	—
Mar 31, 2024	AMC	—	-0.02	—	—	—	—	—	—	—	—	—
Dec 31, 2023	AMC	—	-0.03	—	—	—	—	—	—	—	—	—
Sep 30, 2023	AMC	-13.44	-0.01	+100.0%	—	—	—	—	—	—	—	—
Feb 23, 2023	AMC	-15.30	-17.64	-15.3%	34.68	-2.4%	+19.0%	-7.0%	-6.2%	-3.8%	+10.6%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Dec 5	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.27	$4.33	+1.4%	+0.0%	+6.3%	+1.3%	-8.5%	-5.5%
Sep 11	Maxim Group	Maintains	Buy → Buy	—	$13.92	$14.01	+0.6%	+0.5%	-7.0%	-7.2%	+3.6%	-15.0%
Aug 26	HC Wainwright & Co.	Maintains	Buy → Buy	—	$7.34	$7.31	-0.4%	+12.7%	+23.6%	+19.5%	-7.2%	+5.5%
Feb 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.10	$5.23	+2.5%	-0.2%	+1.2%	-2.1%	-6.9%	+0.4%

Institutional (13F) — Top 0 All ↗

No 13F holders found.

Mutual Funds / ETFs (N-PORT) — Top 1 All ↗

#	Fund	Shares	Value	Period
1	AdvisorShares Psychedelics ETF	155,367	$632K	Mar 2026

Data updated apr 26, 2026 2:45pm · Source: financialmodelingprep.com